AzTrials
AzTrials

Scoliosis IdiopathicSCOGENNCT05116436

Genetic Study of Idiopathic Scoliosis in a Cohort of Families (SCOGEN)

An observational study of Scoliosis Idiopathic, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study will focus on a large cohort of multiplex families, to precisely identify candidate genes. The fact of have a large database (fifty families, collected by the principal investigator for more than two decades), will contribute to the discovery of genes of interest. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Scoliosis Idiopathic
What is being tested?
Blood sample and Spine X-ray
Type of treatment
Surgery or procedure
How many people
43 participants
Where
1 siteFrance
Study dates
6 Jun 2020to 6 Jun 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Families : patients with idiopathic scoliosis and their relatives

Who may be able to join

  • Presence of idiopathic scoliosis, diagnosed by a clinical examination by an orthopedic doctor and confirmed by the presence of a Cobb angle greater than 10 ° on radiographs of the spine
  • Signed informed consent
  • Affiliation to a social security scheme or beneficiary of such a scheme
  • Be related to the first or second degree with at least 2 individuals suffering from idiopathic scoliosis, and whose family tree over 3 generations finds at least 3 cases of idiopathic scoliosis
  • Do not present with scoliosis (clinical examination by an orthopedic doctor and x-rays of the spine).
  • Affiliation to a social security scheme or beneficiary of such a scheme

Who cannot join

  • Non-inclusion criteria for "sick" patients:
  • Be part of one of the following categories of vulnerable people: protected adults, adults unable to express their consent and not subject to a protection measure, pregnant women, parturients and nursing mothers, people deprived of their liberty, people hospitalized without consent, people admitted to a health or social establishment for purposes other than research
  • Suspicion of scoliosis secondary to clinical examination
  • Non-inclusion criteria for "healthy relatives":
  • Be part of one of the following categories of vulnerable people: protected adults, adults unable to express their consent and not subject to a protection measure, pregnant women, parturients and nursing mothers, people deprived of their liberty, people hospitalized without consent, people admitted to a health or social establishment for purposes other than research
  • Discovery of scoliosis during research (if scoliosis of an idiopathic nature: patient included in the cohort of patients, if secondary scoliosis: exclusion from the family).
  • All patients :
  • Pregnancy in progress or desired with discontinuation of contraception (contraindication to the realization of x-rays).

Trial locations and contacts

1 site in 1 country.

Jean-François Oudet contact

0683346567

jf.oudet@ecten.eu

Marie-Hélène Barba contact

mh.barba@ecten.eu

France1 site, 1 recruiting
  • Clinique Maussins-Nollet

    Paris, 75019

    Jean-François Oudet, 0683346567, jf.oudet@ecten.eu

    Marie-Hélène Barba, mh.barba@ecten.eu

    Recruiting

Other trials in France

About this study

Official title: Genetic Study of Idiopathic Scoliosis in a Cohort of Families

This study will focus on a large cohort of multiplex families, to precisely identify candidate genes. The fact of have a large database (fifty families, collected by the principal investigator for more than two decades), will contribute to the discovery of genes of interest. It will also allow testing for the presence or absence of mutations found in other cohorts in previous studies. The main objective of this study is to identify genetic abnormalities associated with the presence and severity of idiopathic scoliosis, in families of scoliosis.

Being tested
Blood sample, Spine X-ray

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood sampleProcedure or surgery

    It will test the presence or absence of genetic mutations found in other cohorts in previous studies.

  • Spine X-rayProcedure or surgery

    To determine the scoliosis

Study groups in NCT05116436
Study groupRoleWhat they receive
Patient with idiopathic scoliosisNot described
Receives: Procedure: Blood sample; Procedure: Spine X-ray
Healthy related patientsNot described
Receives: Procedure: Blood sample; Procedure: Spine X-ray

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Presence of a mutated allele in scoliosis patients versus their healthy relatives.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Nov 2021
  2. Study start6 Jun 2020
  3. Primary completion6 Jun 2021
  4. Study completion6 Jun 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Family based
Time perspective
Other
Enrolment
43 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05116436
Sponsor's protocol ID
2019-A03136-51
Acronym
SCOGEN
Status last verified
Nov 2021
First submitted
4 Nov 2021
Last updated
11 Nov 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Scoliosis Idiopathic, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jean-François Oudet (0683346567, jf.oudet@ecten.eu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Presence of a mutated allele in scoliosis patients versus their healthy relatives. (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in